CJ Henley, DMD, PA / San Marco, Jacksonville, Florida
Osteoporosis medications and dental work in Jacksonville, FL.
Prolia, Fosamax, Reclast, and keeping your jaw healthy.
Osteoporosis medications and dental care fit together well. Cleanings, fillings, and crowns go ahead as usual on Prolia, Fosamax, or Reclast. The one thing that needs planning is surgery on the jawbone, such as an extraction or an implant, because these drugs carry a small risk of a jaw healing problem called MRONJ. At our San Marco office, Dr. CJ Henley reviews your medication, measures your risk, and coordinates with the doctor who prescribes it.
- <0.05%estimated MRONJ risk at osteoporosis doses, under 5 in 10,000 people1
- <5%estimated risk at the higher doses used for cancer that has spread to bone1
- 62–82%of MRONJ cases follow a tooth extraction1
- Neverstop Prolia on your own: stopping without a plan can lead to spine fractures1,4
Osteoporosis and dental care
Osteoporosis medications and dental health: why your jaw is part of the plan.
Osteoporosis thins bone throughout the body, including the jaws that hold your teeth. The medications that protect your hips and spine also slow bone turnover in the jaw, which can change how the jaw heals after surgery. It doesn’t stop you from getting dental care; it changes how we plan it.
Osteoporosis weakens bone density and strength and raises the risk of fractures. In the mouth, bone quality affects how well teeth are supported, how bone heals after a procedure, and how predictable treatments such as tooth extraction and dental implants will be.
Many people with osteoporosis take a bisphosphonate (Fosamax, Actonel, Boniva, Reclast), denosumab (Prolia), or romosozumab (Evenity). These drugs prevent fractures very well.1 Rarely, they are linked to medication-related osteonecrosis of the jaw (MRONJ), so the type, dose, duration, and timing of your medicine are part of every treatment plan we make.
Dental care for people with osteoporosis is part of our complex, medically involved dental care, where your medical history, your medications, and your dental needs are planned together. We approach it with caution and respect for your overall health. Decisions are guided by long-term health, function, and quality of life, not rushed solutions.
What is MRONJ?
What MRONJ (osteonecrosis of the jaw) is, in plain terms.
MRONJ is an area of jawbone that is exposed in the mouth, or can be felt through a small opening in the gum, and hasn’t healed for more than eight weeks in someone who has taken a bone medication and never had radiation to the jaws. It is rare, usually follows an extraction, and is far more common at cancer doses than at osteoporosis doses.
The American Association of Oral and Maxillofacial Surgeons (AAOMS) sets the definition and the stages most dentists, surgeons, and oncologists use.1 The lower jaw is involved about three times as often as the upper jaw.1 The older name, “bisphosphonate osteonecrosis,” changed to MRONJ once denosumab and other drugs were linked to the same problem.
| Stage | What it means | What you might notice |
|---|---|---|
| At risk | Taking or has taken a bone medication; no exposed bone | Nothing. This is most people on these drugs. |
| Stage 0 | No exposed bone, but symptoms or X-ray changes without another dental cause | A dull jaw ache, a tooth that loosens, swelling, or numbness. Up to half progress, so it gets watched closely. |
| Stage 1 | Exposed bone, or a gum opening that reaches bone; no infection | Often painless. A rough spot your tongue finds. |
| Stage 2 | Exposed bone with infection or inflammation | Pain, redness, swelling, or drainage. |
| Stage 3 | Exposed bone with infection that has spread beyond the tooth-bearing bone | A fracture, an opening to the skin or sinus, or bone loss to the jaw’s lower border. |
Which osteoporosis medications matter
Which osteoporosis medications affect dental work.
Bisphosphonates (alendronate, risedronate, ibandronate, zoledronic acid), denosumab, and romosozumab are the bone drugs linked to MRONJ. The same active drug can come in a low osteoporosis dose and a much higher cancer dose, so the brand name matters: Prolia is not Xgeva, and Reclast is not Zometa.
| Drug (brand) | Type | Usually given | Used for |
|---|---|---|---|
| Alendronate (Fosamax) | Oral bisphosphonate | Pill, usually once a week | Osteoporosis |
| Risedronate (Actonel, Atelvia) | Oral bisphosphonate | Pill, weekly or monthly | Osteoporosis |
| Ibandronate (Boniva) | Bisphosphonate | Monthly pill or an IV dose every three months | Osteoporosis |
| Zoledronic acid (Reclast) | IV bisphosphonate | An infusion once a year | Osteoporosis |
| Denosumab (Prolia) | Antibody (RANK-L inhibitor) | A shot every six months | Osteoporosis |
| Romosozumab (Evenity) | Antibody (sclerostin inhibitor) | Monthly shots for one year, then usually another bone drug | Osteoporosis with high fracture risk |
| Zoledronic acid (Zometa) | IV bisphosphonate, cancer dose | An infusion every three to four weeks | Cancer in the bone, multiple myeloma |
| Denosumab (Xgeva) | Antibody, cancer dose | A shot every four weeks | Cancer in the bone, giant cell tumor |
Bisphosphonates bind to bone and stay there for years after the last dose. Denosumab doesn’t bind to bone, and its effect mostly wears off within about six months of the last shot.1 That difference is why the planning for Fosamax and the planning for Prolia aren’t the same. Some cancer drugs that block blood-vessel growth, along with steroids, can add to the risk, so bring your full medication list.
How big is the risk?
MRONJ risk: osteoporosis doses vs. cancer doses.
At osteoporosis doses, MRONJ is rare: AAOMS estimates under 0.05%, fewer than 5 people in 10,000. At the monthly doses used for cancer in the bone, the risk is roughly 100 times higher, under 5%. Most cases in both groups follow an extraction or other surgery on the jawbone.
Osteoporosis doses
estimated MRONJ risk (Fosamax, Reclast, Prolia, Evenity)1
- Oral bisphosphonates
- About 5 in 10,000 or fewer. In trials, close to the rate in people on a placebo.1
- Reclast once a year
- About 2 in 10,000 or fewer.1
- Prolia
- 0.04% to 0.3%; the higher figure is after ten years of use.1
- Evenity
- 0.03% to 0.05%, similar to alendronate.1
- After an extraction
- 0% to 0.15% on bisphosphonates; about 1% on Prolia in one study.1
Cancer doses
estimated MRONJ risk (Zometa, Xgeva)1
- Zometa
- Usually under 5%, with a range of 0% to 18% depending on how long people were followed.1
- Xgeva
- 0% to 6.9%, similar to Zometa.1
- Over time
- About 1.3% (Zometa) and 1.8% (Xgeva) by three years in one large group.1
- After an extraction
- 1.6% to 14.8%, with most estimates between 1% and 5%.1
Why cancer doses carry more risk
Xgeva is given every four weeks instead of every six months, and Zometa every three to four weeks instead of once a year.5 That is roughly 10 to 13 times more drug each year, often for people who are also having chemotherapy or taking steroids. Cancer itself and immune suppression raise the risk too.1
What else raises the risk
Years on the drug, an extraction or other bone surgery, gum disease or an infected tooth, a denture that rubs, steroids, and some cancer drugs. Diabetes and smoking are reported inconsistently.1 Gum infection is one of the few risks you can lower, which is why regular dental cleanings matter more on these drugs.
These are population estimates from studies, not predictions for any one person. AAOMS notes that the numbers vary widely between studies because MRONJ is rare.1
Fosamax, Actonel, Boniva, Reclast
Bisphosphonates and dental work: what changes and what doesn’t.
With bisphosphonates and dental work, routine care doesn’t change. Cleanings, fillings, crowns, bridges, and dentures are done as usual. Extractions, implants, gum surgery, and bone grafts get a risk review first, and we pick the least invasive way to solve the problem.
Routine on bisphosphonates
- Cleanings and deep cleanings for gum disease
- Exams and X-rays (comprehensive dental exams)
- Fillings, crowns, and bridges
- Root canals, which can save a tooth that would otherwise be pulled (molar root canals are usually referred to an endodontist)
- New dentures and relines, with care to avoid sore spots
Planned first, with a risk review
- Extractions
- Dental implants and bone grafting
- Gum surgery that involves bone
- Treating an abscess or infected tooth before it spreads
- Any surgery after several years on the drug, or with steroids
The ADA’s view
The American Dental Association’s expert panel advised that people taking these drugs for osteoporosis shouldn’t have routine dental care withheld or changed because of them, and that the benefit of the medicine for preventing fractures outweighs the small jaw risk for most people.2,3
Five years and longer
AAOMS reports mixed data on whether years on a bisphosphonate raise the jaw risk at osteoporosis doses; a large trial found no clear rise up to nine years.1 We still note how long you’ve taken it, because duration is a risk factor at every dose.
Denosumab
Prolia and dental work: timing, Xgeva, and why you shouldn’t stop.
With Prolia and dental work, routine care goes ahead at any time. For an extraction or implant, timing can help: AAOMS describes doing jawbone surgery about three to four months after the last shot, when the drug’s effect is fading. Never skip or delay a Prolia dose on your own; stopping it can cause rapid bone loss and spine fractures.
Prolia vs. Xgeva. Both are denosumab. Prolia is 60 mg every six months for osteoporosis. Xgeva is 120 mg every four weeks for cancer in the bone, about 13 times as much drug in a year.5 Prolia’s MRONJ risk is low (0.04% to 0.3%); Xgeva’s is in the same range as Zometa’s, under 5% in most studies.1
Timing around a Prolia shot. When surgery on the bone is needed, AAOMS describes planning it about three to four months after the last Prolia dose and restarting the drug six to eight weeks after surgery, which keeps any gap short.1 Because Prolia is given every six months, that window often fits the normal schedule. Your prescriber makes that call, and we work out the date with them.
Several studies show bone loss speeds up after denosumab is stopped, raising the risk of several spine fractures at once.1,4 If Prolia is ever stopped, physicians usually plan a follow-up drug. That decision belongs to the doctor who prescribes it, not to a dental appointment.
Should I stop before dental work?
Drug holidays before dental work: what the evidence says.
A drug holiday means pausing a bone medication around dental surgery. The evidence doesn’t show that it prevents MRONJ, and the AAOMS expert panel split evenly on whether to offer one. Only the physician who prescribes your medicine should decide, and never for routine care.
AAOMS calls the evidence on drug holidays inconclusive, because MRONJ is too rare for trials to settle the question.1 Half of its working group would consider a holiday case by case; the other half never recommends one, because the fracture risk of stopping may outweigh any benefit.1 For people with cancer, the benefit of a holiday “remains unsubstantiated.”1 Bisphosphonates stay in bone for years, so a short pause before an extraction changes little. Denosumab is the opposite: its effect fades fast, which is why stopping it carries the rebound risk above.
Here is how we handle it: we never tell you to stop a bone medication. If surgery is needed, Dr. Henley writes to your prescriber with the procedure, the timing, and your dental risk, and your physician decides.
Starting a bone medication?
See a dentist before you start Prolia, Reclast, or Fosamax.
The best time for a dental checkup is before your first dose. Any tooth that may need to come out can be handled while the jaw heals normally. For cancer doses (Xgeva, Zometa) this matters most: AAOMS advises getting the mouth healthy first and, when your oncologist agrees, starting the drug after the sockets heal.
01 Exam
Exam and X-rays
A full exam with X-rays when needed, looking for infection, cracked teeth, deep gum pockets, and loose roots.
02 Fix
Treat problem teeth
Teeth with a poor outlook are removed now; decay and gum infection are treated.
03 Letter
Report to your doctor
A written note to your physician or oncologist on dental readiness and timing.
04 Keep up
Regular recalls
Cleanings and checks on a set schedule, for as long as you take the medicine.
For osteoporosis doses, AAOMS says the timing is less urgent because the risk is so low, but a checkup at the start is still sensible.1 In a study of men with prostate cancer in the bone, a regular dental check program cut the relative risk of MRONJ about 2.5-fold compared with seeing a dentist only for symptoms.1 The same before-treatment approach is used for radiation; see our dental exam before radiation page and dental care during cancer treatment.
Procedures while on bone drugs
Extractions, implants, and dentures while on osteoporosis medications.
Extractions, implants, and dentures are all possible for most people taking osteoporosis medications. Each gets a plan: gentle surgery, closing the site when possible, infection control, and longer follow-up. People on cancer doses usually should avoid implants, according to AAOMS.
Tooth extraction
Extraction is the most common trigger for MRONJ, so it is planned, not rushed.1 Steps linked to lower risk include treating infection first, antimicrobial rinses, antibiotics when indicated, closing the socket where possible, and good oral hygiene.1 Sometimes a tooth that can’t be restored can be kept as a root instead of pulled.1 Dr. Henley does these extractions in our office for patients on osteoporosis doses and on cancer doses such as Xgeva or Zometa, with the extra planning and follow-up the higher dose calls for. Read more on our tooth extraction page.
Dental implants
For osteoporosis doses, the data on dental implants are limited and conflicting; one large study even found lower jaw-necrosis risk in people with implants.1 AAOMS advises informed consent about the low risk of MRONJ and of early or late implant failure, plus long-term recall.1 For people on cancer doses, AAOMS says implants should be avoided.1 Our post on how dental implants work explains the basics.
Dentures and sore spots
A denture that rubs can expose bone, most often on the inside of the lower jaw near the back. Among people on cancer-dose bisphosphonates, denture wearers had about twice the risk.1 We check new dentures and partials for pressure spots and adjust them early. Don’t ignore a sore that doesn’t heal in a week or two.
Infections and abscesses
Gum disease or an infected tooth is a risk factor in about half of cancer patients with MRONJ.1 Treating a tooth abscess or active gum infection early is part of prevention, not something to postpone because of your medicine.
Signs of osteonecrosis of the jaw
Early signs of MRONJ to report right away.
The classic sign of MRONJ is a patch of hard, yellow-white bone showing through the gum that doesn’t heal, often painless at first. Earlier signs can be a socket that won’t heal, a dull jaw ache, a tooth that loosens without gum disease, swelling, or numbness of the lip or chin.
you take or have taken a bone medication and notice exposed bone, a socket that hasn’t healed, swelling, or numbness. Call our Jacksonville office at 904.398.1549. Many of these signs have common dental causes, and AAOMS notes MRONJ is often confused with dry socket, gum infection, or sinus problems,1 so an exam sorts it out. See dry socket and emergency dental care.
MRONJ vs. osteoradionecrosis
MRONJ vs. osteoradionecrosis: drug vs. radiation.
Both are jawbone that dies and won’t heal, and both are often set off by an extraction. The cause is different: MRONJ follows bone medications, while osteoradionecrosis (ORN) follows radiation to the head and neck. By definition, someone who had radiation to the jaws is evaluated for ORN, not MRONJ.
| MRONJ | Osteoradionecrosis (ORN) | |
|---|---|---|
| Cause | Bisphosphonates, denosumab, romosozumab, sometimes with other drugs | Radiation therapy to the head and neck |
| Where | Either jaw, mostly the lower jaw | Inside the radiation field, mostly the lower jaw |
| Common trigger | Extraction or bone surgery | Extraction or bone surgery in the radiated area |
| Prevention | Dental care before the first dose; planned surgery | A dental exam before radiation; lifelong care |
AAOMS notes that the risk of MRONJ after an extraction in higher-risk patients is similar to the risk of ORN after an extraction in radiated patients, roughly 1% to 5%.1 If you have had both radiation and a bone medication, as some people with head and neck cancer have, your plan accounts for both. Read our full page on osteoradionecrosis of the jaw.
Our approach
How we care for patients on osteoporosis medications in Jacksonville.
Dr. Henley reviews your bone medication, dose, and history, assesses your MRONJ risk, and plans dental work with the doctor who prescribes your medicine. He writes consult letters to physicians and oncology teams, usually within one to two days of your visit. If MRONJ develops, he treats early stages (stage 0 and 1) in our office and refers more advanced cases to an oral and maxillofacial surgeon, staying involved in your care.
Medication and history review
Which drug, what dose, how long, the date of your last Prolia shot or Reclast infusion, steroids, other cancer drugs, and why you take it. Bring your list and your prescriber’s contact.
Exam and risk assessment
A full exam, gum measurements, and X-rays when needed. We look for infection, failing teeth, denture sore spots, and any early sign of MRONJ, and tell you your risk in plain numbers.
Conservative plan
Prevention first: early treatment of decay and gum disease, root canals or crowns to save teeth where possible, and personal home-care advice. Surgery only when it is truly needed.
Coordination with your physician
A consult letter to your physician, endocrinologist, or oncologist covering the planned procedure and timing, usually within one to two days of your visit. Medication changes are their decision.
Follow-up
Regular recalls to monitor your teeth, gums, and bone, and longer follow-up after any surgery.
Dr. Henley is a general dentist with advanced training in oral medicine who serves on the Head & Neck Tumor Board at Baptist MD Anderson. Physicians can use our physician referral information to send patients before the first dose. This work is part of our oral medicine and diagnosis services.
Cost and insurance
Cost and insurance for dental care on bone medications.
An MRONJ risk review is part of your exam. Any treatment that follows, such as an extraction or an implant, is priced for your case, and we give you the fee before treatment begins.
We are an out-of-network practice. Some dental plans cover part of exams, X-rays, and treatment, often with a frequency limit. We can help you understand how to use your benefits; you are responsible for amounts your plan does not pay. Call our team with your plan details to ask about fees and payment arrangements. See dental insurance and payment.
Near you
Dental care on osteoporosis medications in San Marco, for all of Jacksonville.
Dr. CJ Henley sees every patient himself and plans dental work around Prolia, Fosamax, Reclast, Evenity, Xgeva, and Zometa. Patients come to our San Marco office from across Jacksonville and Northeast Florida, and physicians and oncologists can refer patients before a first dose.
Call to book, read our reviews, meet our team, or start with the new-patient forms. Patients nearby can also read our Mandarin, Riverside and Avondale, and Ponte Vedra pages.
San Marco and Southbank
On Hendricks Avenue, in the neighborhood
A risk review fits into a lunch hour.
Riverside, Avondale, and Ortega
Across the St. Johns River on the Fuller Warren Bridge
A short trip before a first Prolia shot.
San Jose and Mandarin
North on San Jose Boulevard, which becomes Hendricks Avenue
One road from Mandarin to our door.
Southside and Baymeadows
North on I-95 from Baymeadows Road
Easy to fit around a doctor’s visit.
Jacksonville Beach, Neptune Beach, and Atlantic Beach
West on Atlantic Boulevard or Beach Boulevard
Recalls booked ahead so you make one trip at a time.
Ponte Vedra and Nocatee
West on J. Turner Butler Boulevard, then north on I-95
Surgery dates planned around your Prolia schedule.
Orange Park and Fleming Island
North on US-17 to I-95, then across the Fuller Warren Bridge
We coordinate with your physician by letter.
St. Augustine
North on I-95
Worth the drive for coordination with your oncology team.
Frequently asked questions
Questions about osteoporosis medications and dental work.
Can I go to the dentist if I take osteoporosis medication?
Yes, and you should keep going. Exams, cleanings, fillings, and crowns are routine on Prolia, Fosamax, Reclast, and similar drugs. Tell us which medicine you take and for how long. Only surgery on the jawbone, such as an extraction or implant, needs extra planning.
Can I have a tooth pulled while on Prolia?
Usually yes, with planning. At osteoporosis doses the MRONJ risk after an extraction is low, about 1% in one Prolia study. We review your dose and timing, treat any infection first, and coordinate the date with your prescriber, often about three to four months after your last shot.
Should I stop Prolia before dental work?
No, not on your own. Stopping or delaying denosumab can cause rapid bone loss and multiple spine fractures. If surgery is needed, your prescriber decides whether to adjust the timing of your next dose. For cleanings and fillings, nothing changes.
How long after a Prolia injection can I have dental work?
Routine dental work can be done at any time. For an extraction or implant, AAOMS describes doing surgery about three to four months after the last Prolia dose, when its effect is fading, and restarting six to eight weeks after surgery. Your physician makes the final call.
Should I stop Fosamax or take a drug holiday before an extraction?
Only if the doctor who prescribes it decides to. Evidence that a drug holiday prevents MRONJ is inconclusive, and AAOMS experts are split on it. Bisphosphonates stay in bone for years, so a short pause changes little. We send your physician the details and let them decide.
Can I get dental implants if I take bisphosphonates or Prolia?
Often yes at osteoporosis doses, after a risk review and informed consent about the low risk of MRONJ and of early or late implant failure, with long-term recalls. AAOMS advises avoiding implants for people on cancer doses such as Xgeva or Zometa.
What is MRONJ?
Medication-related osteonecrosis of the jaw (MRONJ) is exposed jawbone, or bone that can be felt through an opening in the gum, that hasn’t healed for more than eight weeks in someone who has taken a bone medication and never had radiation to the jaws.
How common is osteonecrosis of the jaw from osteoporosis drugs?
Rare. AAOMS estimates under 0.05% at osteoporosis doses: 5 in 10,000 or fewer on oral bisphosphonates, 2 in 10,000 or fewer on yearly Reclast, and 0.04% to 0.3% on Prolia. At cancer doses the risk is higher, under 5%.
What are the first signs of osteonecrosis of the jaw?
Exposed bone on the gum that doesn’t heal, an extraction socket that stays open, a dull jaw ache, swelling or drainage, a tooth that loosens without gum disease, or numbness of the lip or chin. Early MRONJ is often painless, so report any of these.
Is Prolia or Fosamax riskier for the jaw?
At osteoporosis doses both are low risk. AAOMS puts Prolia’s range a bit higher, 0.04% to 0.3%, than oral bisphosphonates, 0.05% or lower. Fosamax stays in bone for years; Prolia wears off within months, which is why stopping Prolia carries a fracture risk.
Do Reclast, Evenity, or Boniva cause jaw problems?
They can, rarely. Yearly Reclast is estimated at 2 in 10,000 or fewer, and Evenity at 0.03% to 0.05%, similar to alendronate. Boniva is a bisphosphonate in the same low range at osteoporosis doses. Tell us about any of them, including past use.
What is the difference between Prolia and Xgeva?
Both are denosumab. Prolia is 60 mg every six months for osteoporosis. Xgeva is 120 mg every four weeks for cancer in the bone, about 13 times as much drug a year, and its MRONJ risk is much higher. The planning for Xgeva is more cautious.
Should I see a dentist before starting osteoporosis medication?
Yes, ideally. A checkup before the first dose lets us treat infection and remove failing teeth while your jaw heals normally. For cancer doses it is strongly advised, and the drug is often started after the mouth has healed, if your oncologist agrees.
What is the difference between MRONJ and osteoradionecrosis?
Both are jawbone that dies and won’t heal. MRONJ is caused by bone medications; osteoradionecrosis is caused by radiation to the head and neck. Someone who had radiation to the jaws is evaluated for osteoradionecrosis instead.
What happens if I develop MRONJ?
Call us promptly. Dr. Henley examines the area and rules out common look-alikes such as dry socket or gum infection. Early MRONJ (stage 0 or 1) is treated in our office with antimicrobial rinses, antibiotics when needed, removal of loose pieces of bone, and close follow-up. More advanced stages are referred to an oral and maxillofacial surgeon, and we coordinate with your surgeon and physician.
Will you talk to my doctor or write a letter?
Yes. Dr. Henley writes consult letters to physicians, endocrinologists, and oncology teams covering your dental findings, the planned procedure, and the timing, usually within one to two days of your visit. Bring your prescriber’s name and phone number to your visit.
Does insurance cover dental care on osteoporosis medications?
Your risk review is part of the exam, and treatment is priced for your case before it begins. We are an out-of-network practice and can help you understand how to use your benefits. Call our team with your plan details to ask about fees before scheduling.
Where can I get dental care on Prolia or Fosamax in Jacksonville?
CJ Henley, DMD, PA is at 3675 Hendricks Avenue, Jacksonville, FL 32207, in San Marco. Patients come from Mandarin, Southside, Riverside, the Beaches, Ponte Vedra, Orange Park, and St. Augustine. Call 904.398.1549 and tell us which bone medication you take.
More reading: How dental implants work · Medically complex dental care · Osteoradionecrosis
Your next step
On a bone medication, or about to start one?
Book a checkup and MRONJ risk review at our Jacksonville office before your first dose, or before any extraction or implant. If you notice exposed bone, swelling, or a socket that won’t heal, call us now.
CJ Henley, DMD, PA3675 Hendricks Avenue
Jacksonville, FL 32207
Prefer a nonurgent text? 904.762.5616 is our practice on-call and text line. Please don’t send sensitive health information by text, and call for anything urgent.
Related pages
Sources
- Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws: 2022 update. J Oral Maxillofac Surg. 2022;80(5):920-943.
- American Dental Association. Oral Health Topics: Osteoporosis medications and medication-related osteonecrosis of the jaw.
- Hellstein JW, Adler RA, Edwards B, et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2011;142(11):1243-51.
- Tsourdi E, Zillikens MC, Meier C, et al. Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab. Published online October 26, 2020.
- U.S. prescribing information via DailyMed (National Library of Medicine): Prolia, Xgeva, Reclast, Zometa, Evenity.
- Peterson DE, Koyfman SA, Yarom N, et al. Prevention and management of osteoradionecrosis in patients with head and neck cancer treated with radiation therapy: ISOO-MASCC-ASCO guideline. J Clin Oncol. 2024;42(16):1975-1996.